NUTRITION 21, LLC ANNOUNCES THE PRESENTATION OF A CLINICAL EVALUATION OF THE DURATION OF THE EFFECT OF NITROSIGINE®

PURCHASE, NEW YORK – APRIL 6, 2016 – Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of new clinical study results supporting the bioavailability of Nitrosigine® bonded arginine silicate (ASI), titled, “A Pharmacokinetic Evaluation of the Duration of Effect of Inositol-Stabilized Arginine Silicate and Arginine Hydrochloride in Healthy Adult Males.” The study was presented on April 3rd, 2016 to scientists and other professionals at the acclaimed Experimental Biology 2016 annual meeting …

READ MORE